Literature DB >> 15055469

Fat body mass, leptin and femur bone mineral density in hip-fractured women.

M Di Monaco1, F Vallero, R Di Monaco, F Mautino, A Cavanna.   

Abstract

Fat body mass (FBM) is a strong predictor of both bone mineral density (BMD) and risk of hip fracture, but the mechanisms responsible are not completely understood. We addressed whether leptin is the link between FBM and BMD in hip-fractured women. Sixty-two of 74 women with hip fractures were evaluated. Serum leptin was measured by radioimmunoassay, 23.4+/-9.1 days (mean+/-SD) after fracture occurrence. BMD and body composition were assessed by dual-energy X-ray absorptiometry (DXA). As expected, a positive linear correlation was found between FBM and both leptin (r=0.782; p<0.001) and femur BMD measured at five sites (r value ranging from 0.293 to 0.498 depending on the site of the femur BMD assessment, p<0.05). A positive correlation between leptin and BMD measured at the intertrochanteric area (r=0.259; p<0.05) but not at the other four sites was shown. At linear multiple regression [dependent variable = femur BMD; independent variables = age, weight, height, body mass index, fracture type, term fracture-DXA, Barthel index score, FBM, lean body mass, serum PTH, serum 25(OH)vitamin D and leptin], FBM was positively associated with BMD measured at all the five sites. The association between leptin and BMD was inverse and it was significant at four of the five sites of the BMD assessment. In conclusion, in a sample of hip-fractured women, the positive association between FBM and femur BMD was not explained by serum leptin. On the contrary, after adjustment for FBM and other confounding variables, an inverse association between leptin and BMD was found.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15055469     DOI: 10.1007/BF03349154

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  30 in total

1.  Serum leptin levels are associated with bone mass in nonobese women.

Authors:  J A Pasco; M J Henry; M A Kotowicz; G R Collier; M J Ball; A M Ugoni; G C Nicholson
Journal:  J Clin Endocrinol Metab       Date:  2001-05       Impact factor: 5.958

2.  Effect of subcutaneous leptin replacement therapy on bone metabolism in patients with generalized lipodystrophy.

Authors:  Vinaya Simha; Joseph E Zerwekh; Khashayar Sakhaee; Abhimanyu Garg
Journal:  J Clin Endocrinol Metab       Date:  2002-11       Impact factor: 5.958

3.  Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass.

Authors:  P Ducy; M Amling; S Takeda; M Priemel; A F Schilling; F T Beil; J Shen; C Vinson; J M Rueger; G Karsenty
Journal:  Cell       Date:  2000-01-21       Impact factor: 41.582

4.  Loss of bone density and lean body mass after hip fracture.

Authors:  K M Fox; J Magaziner; W G Hawkes; J Yu-Yahiro; J R Hebel; S I Zimmerman; L Holder; R Michael
Journal:  Osteoporos Int       Date:  2000       Impact factor: 4.507

5.  Body size and hip fracture risk in older women: a prospective study. Study of Osteoporotic Fractures Research Group.

Authors:  K E Ensrud; R C Lipschutz; J A Cauley; D Seeley; M C Nevitt; J Scott; E S Orwoll; H K Genant; S R Cummings
Journal:  Am J Med       Date:  1997-10       Impact factor: 4.965

6.  Role of serum leptin, insulin, and estrogen levels as potential mediators of the relationship between fat mass and bone mineral density in men versus women.

Authors:  T Thomas; B Burguera; L J Melton; E J Atkinson; W M O'Fallon; B L Riggs; S Khosla
Journal:  Bone       Date:  2001-08       Impact factor: 4.398

7.  Plasma leptin concentrations are associated with bone mineral density and the presence of vertebral fractures in postmenopausal women.

Authors:  M Yamauchi; T Sugimoto; T Yamaguchi; D Nakaoka; M Kanzawa; S Yano; R Ozuru; T Sugishita; K Chihara
Journal:  Clin Endocrinol (Oxf)       Date:  2001-09       Impact factor: 3.478

8.  Relationship of leptin to bone mineralization in children and adolescents.

Authors:  James N Roemmich; Pamela A Clark; Christos S Mantzoros; Cathy M Gurgol; Art Weltman; Alan D Rogol
Journal:  J Clin Endocrinol Metab       Date:  2003-02       Impact factor: 5.958

9.  Relationship between serum leptin concentrations and bone mineral density as well as biochemical markers of bone turnover in women with postmenopausal osteoporosis.

Authors:  Mohamed Shaarawy; Asmaa Farid Abassi; Hany Hassan; Mahmoud E Salem
Journal:  Fertil Steril       Date:  2003-04       Impact factor: 7.329

10.  Leptin reduces ovariectomy-induced bone loss in rats.

Authors:  B Burguera; L C Hofbauer; T Thomas; F Gori; G L Evans; S Khosla; B L Riggs; R T Turner
Journal:  Endocrinology       Date:  2001-08       Impact factor: 4.736

View more
  8 in total

1.  Hypothalamic leptin gene therapy prevents weight gain without long-term detrimental effects on bone in growing and skeletally mature female rats.

Authors:  Urszula T Iwaniec; Stéphane Boghossian; Cynthia H Trevisiol; Thomas J Wronski; Russell T Turner; Satya P Kalra
Journal:  J Bone Miner Res       Date:  2011-07       Impact factor: 6.741

2.  Skeletal muscle mass, fat mass, and hip bone mineral density in elderly women with hip fracture.

Authors:  Marco Di Monaco; Fulvia Vallero; Roberto Di Monaco; Rosa Tappero; Alberto Cavanna
Journal:  J Bone Miner Metab       Date:  2007-06-25       Impact factor: 2.976

3.  Computed tomographic measurements of thigh muscle cross-sectional area and attenuation coefficient predict hip fracture: the health, aging, and body composition study.

Authors:  Thomas Lang; Jane A Cauley; Frances Tylavsky; Douglas Bauer; Steven Cummings; Tamara B Harris
Journal:  J Bone Miner Res       Date:  2010-03       Impact factor: 6.741

4.  Interactions between Serum Adipokines and Osteocalcin in Older Patients with Hip Fracture.

Authors:  Alexander Fisher; Wichat Srikusalanukul; Michael Davis; Paul Smith
Journal:  Int J Endocrinol       Date:  2012-02-22       Impact factor: 3.257

5.  Clinical profiles and risk factors for outcomes in older patients with cervical and trochanteric hip fracture: similarities and differences.

Authors:  Alexander A Fisher; Wichat Srikusalanukul; Michael W Davis; Paul N Smith
Journal:  J Trauma Manag Outcomes       Date:  2012-02-15

Review 6.  Diabetes, diabetic complications, and fracture risk.

Authors:  Ling Oei; Fernando Rivadeneira; M Carola Zillikens; Edwin H G Oei
Journal:  Curr Osteoporos Rep       Date:  2015-04       Impact factor: 5.096

7.  Inverse association of plasma leptin with cortical thickness at distal radius determined with a quantitative ultrasound device in patients with type 2 diabetes mellitus.

Authors:  Masafumi Kurajoh; Masaaki Inaba; Koka Motoyama; Nagato Kuriyama; Etsuko Ozaki; Teruhide Koyama; Shinsuke Yamada; Tomoaki Morioka; Yasuo Imanishi; Masanori Emoto
Journal:  J Diabetes Investig       Date:  2019-06-05       Impact factor: 4.232

Review 8.  Melanocortin-4 receptor complexity in energy homeostasis,obesity and drug development strategies.

Authors:  Munazza Tamkeen Fatima; Ikhlak Ahmed; Khalid Adnan Fakhro; Ammira Sarah Al-Shabeeb Akil
Journal:  Diabetes Obes Metab       Date:  2022-01-11       Impact factor: 6.408

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.